Such a high prevalence of SPARCL1 hypermethylation in the UTUC samples indicates that the loss of SPARCL1 function might be considered to have clinical utility in the assessment of UTUC behavior. The gene discussed is SPARCL1; the disease is renal pelvis/ureter urothelial carcinoma.